In July, the FDA released its revised draft guidance for in vitro diagnostic multivariate index assays (IVDMIAs). The FDA issued a previous guidance last year (see IBO 11/15/06). The draft guidance’s language has been revised to clarify the definition of an IVDMIA and provides examples of tests that are and are not IVDMIAs. The revised […]
The Economist Intelligence Unit (EIU) predicts that prices for industrial commodities, measured by the EIU’s Industrial Raw Materials (IRM) index, will rise by an average of 12% this year. These high prices have not affected demand, partially because prices of all commodities have risen, making substitution less likely. An even greater driver of demand is […]
Called Ilha Formosa (beautiful island) by Portuguese explorers, Taiwan has proven to be an attractive location for an array of high-tech industries. Revenue at Taiwan’s three major science parks—Hsinchu Science Park, the Central Taiwan Science Park and the Southern Taiwan Science Park—is expected to top TWD 2 trillion ($60.8 billion) in 2007, according to Taiwan’s […]
San Francisco’s Moscone Convention Center again hosted the 2007 Semicon West exposition, which ran July 16–20. Last year, IBO noted a certain levity among the booths and exhibits (see IBO 7/15/06), as spirits were doubtless buoyed by the surge of business in 2006. Indeed, sales of semiconductor equipment in 2006 surpassed even the generous growth […]
According to the results of survey published in June by, the top three choices for outsourced R&D were other companies (48.1%), independent R&D organizations (38.9%) and academia (35.1%). The two most popular types of outsourced work were new product innovations (32.1%) and new process innovations (31.3%). The two most common reasons for outsourcing were the […]
The Cancer Biomarkers Collaborative (CBC), a joint project of the American Association for Cancer Research, the FDA and the National Cancer Institute (NCI), is one of a number of collaborations designed to integrate biomarkers into drug development. The CBC will draft guideline recommendations for the FDA’s Critical Path Initiative in the following areas: collecting biospecimens […]
Compared with R&D powerhouses such as the US and Japan, a number of countries in Europe have low R&D spending levels. Many of the newly elected leaders of European nations emphasized the importance of improving R&D performance during their campaigns. IBO examined three countries that have recently elected new leaders to determine how well these […]
R&D spending by analytical and life science instrument companies showed a robust increase last year, according to IBO’s annual survey of R&D spending, indicating healthy business conditions and an optimistic forecast among instrument companies. In fact, several companies, both large and small, made sizable increases to R&D. R&D spending by the 15 instrument companies surveyed […]
The UN’s Food and Agriculture Organization and World Health Organization announced that the Codex Alimentarius Commission (CAC) has adopted 44 new and amended food codes and standards, and established a set of risk-analysis principles to assist governments in making their own standards and codes. Among the new and revised standards and codes are a code […]
The Department of Energy (DOE) announced that it will invest $375 million to support three new Bioenergy Research Centers from fiscal year 2008 to fiscal year 2013. The Centers will be established in Oakridge, Tennessee; Madison, Wisconsin; and near Berkeley, California. The Centers will be hubs of collaboration, staffed by groups of researchers from 18 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
